bioAffinity Technologies entered into a distribution agreement with AvMEDICAL to market its CyPath Lung diagnostic test within the federal healthcare sector, including U.S. Department of Veteran Affairs medical centers. The partnership leverages AvMEDICAL's status as a Service-Disabled Veteran-Owned Small Business and its existing government procurement channels to expand commercial reach. bioAffinity operates in the biotechnology industry, developing noninvasive diagnostics for early detection of lung cancer.
